Overview
Vivek Tanavde practices practicing medicine in Singapore, Singapore.
Mr. Tanavde is highly rated in 1 condition, according to our data. His clinical expertise encompasses Oral Squamous Cell Carcinoma, Cataract, and Tissue Biopsy.
He is actively involved in clinical research, co-authoring 31 peer reviewed articles.
Gender
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Vivek M. Tanavde
Is Vivek M. Tanavde a top-rated expert for Tissue Biopsy?
MediFind is an objective health platform that identifies experts based on real-world data. Vivek M. Tanavde is classified as an Advanced expert for Tissue Biopsy, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Vivek M. Tanavde participate in research or clinical trials?
Yes. Vivek M. Tanavde has published 31 articles and abstracts on conditions like Tissue Biopsy. You can view a list of Vivek M. Tanavde's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Advanced
- Tissue BiopsyMr. Tanavde isAdvanced. Learn about Tissue Biopsy.
- Experienced
- CataractMr. Tanavde isExperienced. Learn about Cataract.
- Oral Squamous Cell CarcinomaMr. Tanavde isExperienced. Learn about Oral Squamous Cell Carcinoma.